CAZZANIGA MARINA ELENA

Ruolo: 
Ricercatore a tempo determinato
Settore scientifico disciplinare: 
ONCOLOGIA MEDICA (MED/06)

Pubblicazioni

  • Caruso, A., Caccuri, F., Bugatti, A., Zani, A., Vanoni, M., Bonfanti, P., et al. (2021). Methotrexate inhibits SARS-CoV-2 virus replication "in vitro". JOURNAL OF MEDICAL VIROLOGY, 93(3), 1780-1785. Dettaglio
  • Bani, M., Rossi, E., Cortinovis, D., Russo, S., Gallina, F., Hillen, M., et al. (2021). Validation of the Italian version of the full and abbreviated Trust in Oncologist Scale. EUROPEAN JOURNAL OF CANCER CARE, 30(1) [10.1111/ecc.13334]. Dettaglio
  • Zeppellini, A., Galimberti, S., Leone, B., Pacifico, C., Riva, F., Cicchiello, F., et al. (2021). Comparison of tumor microenvironment in primary and paired metastatic ER+/HER2- breast cancers: results of a pilot study. BMC CANCER, 21(1), 260-270 [10.1186/s12885-021-07960-z]. Dettaglio
  • Capici, S., Sala, L., Galimberti, S., Valsecchi, M., Squillace, N., Gustinetti, G., et al. (2021). The role for tocilizumab in covid-19 patients: Reflections on monza cohort data. INFECTION AND DRUG RESISTANCE, 14, 1389-1392. Dettaglio
  • Jacobs, S., Robidoux, A., Abraham, J., Pérez-Garcia, J., La Verde, N., Orcutt, J., et al. (2020). Correction to: NSABP FB-7: a phase II randomized neoadjuvant trial with paclitaxel + trastuzumab and/or neratinib followed by chemotherapy and postoperative trastuzumab in HER2+ breast cancer. BREAST CANCER RESEARCH, 22(1). Dettaglio